Publications by authors named "Rachel Sanborn"

27Publications

Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.

J Clin Oncol 2016 09 6;34(26):3119-25. Epub 2016 Jun 6.

Christophe Massard, Institut Gustave Roussy Cancer Centre, Villejuif, France; Michael S. Gordon, Pinnacle Oncology Hematology, Scottsdale, AZ; Sunil Sharma, Huntsman Cancer Institute, Salt Lake City, UT; Saeed Rafii, Sarah Cannon Research Institute, London, UK; Zev A. Wainberg and Alexandra Drakaki, University of California, Los Angeles; and Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Jason Luke and Peter H. O'Donnell, University of Chicago Comprehensive Cancer Center, Chicago, IL; Tyler J. Curiel, The University of Texas Health Science Center, San Antonio, TX; Gerardo Colon-Otero and Winston Tan, Mayo Clinic, Jacksonville, FL; Rachel E. Sanborn, Providence Cancer Center, Portland, OR; John F. Kurland, Marlon C. Rebelatto, Xiaoping Jin, John A. Blake-Haskins, and Ashok Gupta, MedImmune, Gaithersburg, MD; and Neil H. Segal, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.9761DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569690PMC
September 2016

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.

J Clin Oncol 2015 Jan 1;33(2):189-94. Epub 2014 Dec 1.

Martin J. Edelman, Josephine Feliciano, Yang Yang, and Michelle Medeiros, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Ming T. Tan, Georgetown University, Washington, DC; Mary J. Fidler, Rush University Medical Center, Chicago, IL; Rachel E. Sanborn, Providence Portland Medical Center, Portland, OR; Greg Otterson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Lecia V. Sequist, Massachusetts General Hospital Cancer Center, Boston, MA; Tracey L. Evans, University of Pennsylvania, Philadelphia, PA; Bryan J. Schneider, Weill Cornell Medical College, New York City; Roger Keresztes, State University of New York Stony Brook, Stony Brook, NY; John S. Rogers, West Virginia University School of Medicine, Morgantown, WV; Jorge Antunez de Mayolo, Mercy Research Institute, Miami, FL; and Sara L. Zaknoen, Tragara, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5789DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890680PMC
January 2015

Cisplatin versus carboplatin in NSCLC: is there one "best" answer?

Authors:
Rachel E Sanborn

Curr Treat Options Oncol 2008 Dec 19;9(4-6):326-42. Epub 2009 Feb 19.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan St., 2N35, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-009-0085-5
Publisher Site
http://dx.doi.org/10.1007/s11864-009-0085-5DOI Listing
December 2008

Erlotinib: applications in therapy and current status of research.

Expert Rev Clin Pharmacol 2009 Jan;2(1):15-36

Robert W Franz Cancer Research Center, Earle A Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan St, 2N35, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2.1.15DOI Listing
January 2009

Adjuvant therapy for non-small cell lung cancer with mediastinal nodal involvement.

Thorac Surg Clin 2008 Nov;18(4):423-35

Providence Portland Medical Center, 4805 NE Glisan Street, 2N35, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S154741270800073
Publisher Site
http://dx.doi.org/10.1016/j.thorsurg.2008.08.004DOI Listing
November 2008

Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.

Thorac Surg Clin 2008 Nov;18(4):403-15

Department of Surgery, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S154741270800067
Publisher Site
http://dx.doi.org/10.1016/j.thorsurg.2008.07.004DOI Listing
November 2008

Definitive chemoradiotherapy for non-small cell lung cancer with N2 disease.

Thorac Surg Clin 2008 Nov;18(4):393-401

Department of Radiation Oncology, Fred Hutchinson Cancer Research Center, University of Washington, 1959 NE Pacific Street, Box 356043, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thorsurg.2008.07.003DOI Listing
November 2008

Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.

Dermatol Clin 2008 Jan;26(1):103-19, ix

Division of Hematology and Medical Oncology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Mail Code L586, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.det.2007.08.006DOI Listing
January 2008

The safety of bevacizumab.

Expert Opin Drug Saf 2006 Mar;5(2):289-301

Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health and Science University Cancer Institute, Mail Code L586, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.5.2.289DOI Listing
March 2006

Gastrointestinal stromal tumors and the evolution of targeted therapy.

Clin Adv Hematol Oncol 2005 Aug;3(8):647-57

Oregon Health and Science University Cancer Institute, Portland, Oregon 97239, USA.

View Article

Download full-text PDF

Source
August 2005

Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?

Semin Oncol 2005 Feb;32(1):69-75

Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009377540400464
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2004.09.035DOI Listing
February 2005